SXSW was one of the first industry conferences cancelled in 2020 due to the COVID-19 global pandemic. But SXSW is back and W2O is a proud sponsor. Although we won't be eating BBQ together in Austin, we are surfacing meaningful conversations about digital transformation, health equity, vaccine confidence, and the long-term impact of COVID-19.
In the media
Here is the view from MM&M (Medical Marketing & Media).
“W2O landed 5 digital AOR and digital media assignments, including work from Dermira, Bayer and Boehringer Ingelheim. In the wake of the additions, W2O can reasonably claim to have the most diversified healthcare roster in the industry.
‘We’ll continue to focus on expanding in EMEA, coupled with building our scientific communications and market access capabilities,’ said founder & CEO Jim Weiss.”
What we're saying in other publications
W2O's leaders are often tapped for perspectives and guidance.
What other people are sharing with us.
W2O is known for connecting thought leaders, so we’ve created a library of insights leaders of industry have shared with us. People like Sean Hogan, for example…
General Manager, IBM Healthcare & Life Sciences
Connected through W2O’s VIP Luncheon at JP Morgan 2017
Our produced pieces
We work hard to create great materials, and our podcasts and publications have amassed an enthusiastic following. Explore and see why people love our What 2 Know podcast, The Social Oncology Project, Value Report and Dose of Intelligence newsletter.
2018 Social Oncology Project | W2O’s Sixth Edition
See how the online behavior of providers and institutions intersect with real world metrics and what topics trended across the conversation of pricing, value and access of anti-cancer medicines.
W2O’s weekly wrap-up and analysis of biopharma pricing and value news, by Brian Reid, W2O’s Managing Director of Earned Media.
The Social Diabetes Project
We focused on the history of the online #diabetes community, in partnership with Kerri Sparling, Founder of Six Until Me.